Cellular & Molecular Immunology

Papers
(The H4-Index of Cellular & Molecular Immunology is 62. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death947
NLRP3 inflammasome activation and cell death623
Tumor-infiltrating lymphocytes in the immunotherapy era481
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities360
An update on the regulatory mechanisms of NLRP3 inflammasome activation360
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity267
Macrophages and the maintenance of homeostasis236
Neutrophils in chronic inflammatory diseases233
The blood–brain barrier in systemic infection and inflammation227
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases219
Gut microbiome, liver immunology, and liver diseases212
Dendritic cell migration in inflammation and immunity204
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors204
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids191
Unique immunological profile in patients with COVID-19181
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron176
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells175
Metabolism of tissue macrophages in homeostasis and pathology172
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients162
Manganese salts function as potent adjuvants153
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response143
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer137
SARS-CoV-2-specific T cells in infection and vaccination133
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy127
Activation or exhaustion of CD8+ T cells in patients with COVID-19125
The cutting-edge progress of immune-checkpoint blockade in lung cancer120
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors120
Tumor-associated myeloid cells: diversity and therapeutic targeting119
Immunological mechanisms and therapeutic targets of fatty liver diseases117
Dendritic cells in cancer immunology115
Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients113
Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response111
Phages and their potential to modulate the microbiome and immunity107
Neutralizing antibodies for the prevention and treatment of COVID-1998
SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation97
Human immunology and immunotherapy: main achievements and challenges97
Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment92
Neutrophils in liver diseases: pathogenesis and therapeutic targets89
USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy86
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies85
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection84
Immunopathobiology and therapeutic targets related to cytokines in liver diseases83
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant82
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor82
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods82
Impact of intracellular innate immune receptors on immunometabolism80
Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm79
Expansion of atypical memory B cells is a prominent feature of COVID-1979
Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia76
Autoimmmune hepatitis75
Microglia as hackers of the matrix: sculpting synapses and the extracellular space73
Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis71
The aryl hydrocarbon receptor and the gut–brain axis70
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy70
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice70
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract69
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals69
The roles of microglia in viral encephalitis: from sensome to therapeutic targeting67
Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells66
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy66
IFNγ signaling integrity in colorectal cancer immunity and immunotherapy65
Protein N-myristoylation: functions and mechanisms in control of innate immunity62
0.059135913848877